NovaBridge Biosciences (NBP) Goodwill (2018 - 2023)

NovaBridge Biosciences (NBP) has reported Goodwill for 6 consecutive years, with $22.4 million the latest figure, recorded in Q2 2023.

• In Q2 2023, Goodwill fell 7.63% year-over-year to $22.4 million; the TTM figure through Jun 2023 stood at $22.4 million (down 7.63% YoY), while the FY2022 annual figure was $23.6 billion, up 92295.44% from the prior year.
• Goodwill eased to $22.4 million in Q2 2023 per NBP's latest filing, from $22.9 million in the prior quarter.
• Across five years, Goodwill topped out at $25.4 billion in Q4 2021 and bottomed at $22.4 million in Q2 2023.
• Historically, Goodwill has averaged $2.8 billion across 5 years, with a median of $23.9 million in 2020.
• Annual changes were most pronounced in 2021 — Goodwill jumped 103555.76% — and 2022, when it plunged 99.91%.
• NovaBridge Biosciences' Goodwill stood at $23.1 million in 2019, then advanced by 6.35% to $24.5 million in 2020, then surged by 103555.76% to $25.4 billion in 2021, then slumped by 99.91% to $22.9 million in 2022, then slipped by 1.92% to $22.4 million in 2023.
• Business Quant data shows NBP's Goodwill at $22.4 million in Q2 2023, $22.9 million in Q4 2022, and $24.3 million in Q2 2022.